Skip to main content
Keeps Biopharma Inc. logo

Keeps Biopharma Inc. — Investor Relations & Filings

Ticker · 256940 ISIN · KR7256940008 KO Manufacturing
Open in API
Filings indexed 290 across all filing types
Latest filing 2025-03-13 Proxy Solicitation & In…
Country KR South Korea
Listing KO 256940

About Keeps Biopharma Inc.

http://kpscorp.co.kr/

Keeps Biopharma Inc. is a company with operations in both manufacturing and biopharmaceuticals. Its manufacturing activities include the production of equipment for semiconductors and flat panel displays, such as organic light-emitting diodes (OLEDs), as well as cleanroom consumables. Concurrently, the company is expanding its biopharmaceutical business through research and development. Its strategic focus is on building a therapeutic pipeline centered on oncology and metabolic diseases, which includes the development of novel anticancer drugs and combination therapies.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Statement), which is a standard regulatory filing in South Korea (often associated with the DART system) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains the agenda items for the meeting, such as approval of financial statements, changes to the articles of incorporation (including company name change), and election of directors. This document is a formal proxy solicitation material sent to shareholders, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-13 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds into common shares. This type of filing details the issuance of new shares resulting from the conversion of debt, which directly impacts the company's capital structure and share count. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2025-02-28 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the completion of a private placement of exchangeable bonds (securities issuance). It details the issuance amount, payment date, and confirms the completion of the transaction. This falls under the category of capital and financing updates.
2025-02-21 Korean
주요사항보고서(교환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from KPS Corp regarding the issuance of exchangeable bonds (교환사채권 발행결정). It details the terms of the bond, including interest rates, maturity, put options, and the use of proceeds. This is a formal regulatory filing required by the Korea Exchange (KRX) for corporate financing activities. Since it details the specific terms of a capital-raising event (financing) rather than just an announcement of a report, it falls under the 'Capital/Financing Update' category.
2025-02-19 Korean
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a formal regulatory filing from a Korean company (KPS) announcing the acquisition of shares in another company (KB BioMed). This type of disclosure, involving the purchase of equity in another entity for strategic growth, falls under M&A activity or corporate investment disclosures. In the provided taxonomy, 'TAR' (M&A Activity) is the most appropriate category for announcements regarding mergers, acquisitions, or takeover bids.
2025-02-14 Korean
주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a merger decision (회사합병 결정) between KPS (the parent company) and its 100% owned subsidiary, Korea Global Pharmaceutical. It details the merger method, purpose, financial impact, and timeline. This type of filing, which concerns corporate restructuring and M&A activity, is classified under the M&A Activity category.
2025-02-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.